Net Asset Value(s)
LONDON, January 21, 2022--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Cloud Computing UCITS ETF 20.01.2022 CPQ IE00BFD2H405 13,250,0...
- Supported exchanges /
- F /
- 5HB.F
Shanghai Haohai Biological Technology Co. Ltd (5HB F) stock market data APIs
€3.52
0(0%)
as of October 30, 2024
Price chart is built with Anychart
Shanghai Haohai Biological Technology Co., Ltd. engages in the research, development, manufacture, and sale of biomedical materials in China, Europe, the United States, and internationally. The company offers ophthalmology products consisting intraocular lens, medical sodium hyaluronate gel, and lubricant eye drop. It also offers sodium hyaluronate injection, medical chitosan, sodium hyaluronate gel, sodium hyaluronate gel, anti adhesion, and burn wound related products. In addition, the company provides injectors, scalpels, and suture needles. Further, it offers medical aesthetics products comprising Matrifill, a first-generation hyaluronic acid (HA) dermal filler, which is a mono-phase sodium hyaluronate gel for injection; Janlane, a second-generation HA dermal filler for dynamic filling function; Hyalumatrix, a third-generation HA dermal filler that offers precise embellishment function; genetic-engineering preparations for epidermal repair; and radio frequency devices and laser equipment. Additionally, the company is involved in the research and development of biological engineering and pharmaceutical products, as well as in the provision of related technology transfer, and consultation services; sale of professional life and home cosmetology machines; and manufacture and sale of biological reagents, biologicals and biological materials, and other machines and accessories. The company was formerly known as Haohai Limited and changed its name to Shanghai Haohai Biological Technology Co., Ltd. in 2010. Shanghai Haohai Biological Technology Co., Ltd. was founded in 2007 and is headquartered in Shanghai, China.
Shanghai Haohai Biological Technology Co. Ltd Financial Data Overview
| 3.52 | |
| 3.52 | |
| - | |
| 3.52 | |
| 3.52 | |
| 1.5405-4.7 | |
| 1 855 M | |
| 14.6667 | |
| 39 584 K | |
| 2 747 M | |
| 0.0527 | |
| 0.737 |
Our easy-to-use no-coding solutions help you get the data effortlessly:
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
General: {
Code:
'5HB',
Type:
'Common Stock',
Name:
'Shanghai Haohai Biological Technology Co. Ltd',
Exchange:
'F',
CurrencyCode:
'EUR',
CurrencyName:
'Euro',
CurrencySymbol:
'€',
CountryName:
'Germany',
CountryISO:
'DE',
OpenFigi:
NULL,
ISIN:
'CNE100001W69',
CIK:
NULL,
EmployerIdNumber:
NULL,
FiscalYearEnd:
'December',
IPODate:
NULL,
InternationalDomestic:
NULL,
Sector:
'Healthcare',
Industry:
'Biotechnology',
}
Shanghai Haohai Biological Technology Co. Ltd Fundamental Data is available in our Financial Data APIs
- Net Revenue 2 747 M
- EBITDA 567 M
- Earnings Per Share 0.24
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Shanghai Haohai Biological Technology Co. Ltd Earnings via APIs
- Latest Release 2024-10-25
- EPS/Forecast NaN
Get Shanghai Haohai Biological Technology Co. Ltd End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Get Shanghai Haohai Biological Technology Co. Ltd latest news via APIs
Net Asset Value(s)
LONDON, January 20, 2022--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Cloud Computing UCITS ETF 19.01.2022 CPQ IE00BFD2H405 13,250,0...
- BUSINESS WIRE
- NET ASSET VALUE
Do you have any questions?
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
